Lilly-AstraZeneca latest to abandon Alzheimer's drug trials
June 12, 2018 at 08:35 AM EDT
June 12 (Reuters) - Eli Lilly and Co and AstraZeneca Plc said on Tuesday they would discontinue late-stage trials testing their Alzheimer's treatment, the latest among a slew of drugmakers to stop developing treatments for the memory-robbing disease.
